SYSTEM AND METHOD FOR COLLECTION AND DISSEMINATION OF BIOLOGIC SAMPLE TEST RESULTS DATA
A method for collection and dissemination of biologic data, comprising collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips, assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value, receiving the test results at a server disposed on a network, wherein the server has configured thereon a database, assigning a unique identification to the biologic sample, storing the unique identification in the database, storing the test results in the database in association with the unique identification of the biologic sample, and providing access to the database to healthcare organizations for analysis of the test results.
1 . A method for collection and dissemination of biologic data, comprising:
collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips;
assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value;
receiving the test results at a server disposed on a network, wherein the server has configured thereon a database;
assigning a unique identification to the biologic sample;
storing the unique identification in the database;
storing the test results in the database in association with the unique identification of the biologic sample; and
providing access to the database to healthcare organizations for analysis of the test results.
2 . The method of claim 1 , further comprising binding antigens or antibodies of an immune complex to antigens or antibodies included on a control line of a membrane strip.
3 . The method of claim 2 , wherein the control line serves as a control.
4 . The method of claim 3 , wherein the control is a dataset from previously conducted tests stored on a database and accessed by a software application.
5 . The method of claim 1 , wherein the test results include a qualitative result.
6 . The method of claim 1 , wherein the test results include a quantitative result.
7 . The method of claim 6 , wherein the quantitative result is a reaction rating.
8 . The method of claim 1 , wherein a test line of at least one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.
9 . The method of claim 1 , wherein a test line of at least one of the plurality of immunoassay test strips includes Zika virus antigen.
10 . The method of claim 1 , wherein a test line of one of the plurality of immunoassay test strips includes Zika virus antigen and the test line of another one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.
11 . A system for collection and dissemination of biologic data, comprising:
a testing device configured to collect at least one biologic sample, the testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips;
a server remote from the testing device and disposed on a network, the server configured to:
assign correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value;
receive the test results, wherein the server has configured thereon a database;
assigning a unique identification to the biologic sample;
storing the unique identification in a database associated with the server;
storing in the database the test results in association with the unique identification of the biologic sample; and
providing access to the database to healthcare organizations for analysis of the test results.
12 . The system of claim 11 , wherein the testing device is further configured to bind antigens or antibodies of an immune complex to antigens or antibodies included on a control line of a membrane strip of the testing device.
13 . The system of claim 12 , wherein the control line serves as a control.
14 . The system of claim 13 , wherein the control is a dataset from previously conducted tests stored on a database and accessed by a software application.
15 . The system of claim 11 , wherein the test results include a qualitative result.
16 . The system of claim 11 , wherein the test results include a quantitative result.
17 . The system of claim 16 , wherein the quantitative result is a reaction rating.
18 . The system of claim 11 , wherein a test line of at least one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.
19 . The system of claim 11 , wherein a test line of at least one of the plurality of immunoassay test strips includes Zika virus antigen.
20 . The system of claim 11 , wherein a test line of one of the plurality of immunoassay test strips includes Zika virus antigen and the test line of another one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.